CoChat
Sign Up
Cited by 254Inflammatory Bowel DiseaseOcular Diseases and Behçet’s SyndromeSpondyloarthritis Studies and Treatments

Predicting relapse in Crohn’s disease: a biopsychosocial model

Bitton, A, Dobkin, P L, Edwardes, M D, Sewitch, M J, Meddings, J B, Rawal, S, Cohen, A, Vermeire, S +3 more·2008·Gut
DOI 10.1136/gut.2007.134817
Open this paper in CoChat — free account

Abstract

Background: Crohn’s disease (CD) is a chronic relapsing inflammatory bowel disorder. Both biological and psychosocial factors may modulate the illness experience. Aim: The aim of this study was to identify clinical, biological and psychosocial parameters as predictors of clinical relapse in quiescent CD. Methods: Patients in medically induced remission were followed prospectively for 1 year, or less if they relapsed. Disease characteristics were determined at baseline. Serum cytokines, anti- Saccharomyces cerevisiae antibodies, C-reactive protein (CRP), erythrocyte sedimentation rate and intestinal permeability were measured every 3 months. Psychological distress, perceived stress, minor life stressors and coping strategies were measured monthly. A time-dependent multivariate Cox regression model determined predictors of time to relapse. Results: 101 patients (60 females, 41 males) were recruited. Fourteen withdrew and 37 relapsed. CRP (HR = 1.5 per 10 mg/l, 95% CI 1.1 to 1.9, p = 0.007), fistulising disease (HR = 3.2, 95% CI, 1.1 to 9.4, p = 0.04), colitis (HR = 3.5 95% CI 1.2 to 9.9, p = 0.02) and the interaction between perceived stress and avoidance coping (HR = 7.0 per 5 unit increase for both scales, 95% CI 2.3 to 21.8, p = 0.003) were predictors of earlier relapse. Conclusions: In quiescent CD, a higher CRP, fistulising disease behaviour and disease confined to the colon were independent predictors of relapse. Moreover, patients under conditions of low stress and who scored low on avoidance coping (ie, did not engage in social diversion or distraction) were least likely to relapse. This study supports a biopsychosocial model of CD exacerbation.

Integrity signals

Registry

Crossref · 10.1136/gut.2007.134817

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • When restricted to two studies recruiting patients in clinical remission, the risk of flare among those with symptoms of anxiety at baseline was significantly higher (RR = 1.80; 95% CI 1.24-2.61).

    “When we restricted the analysis to include only the two studies that recruited patients in clinical remission,[20, 26] the risk of flare among those with symptoms of anxiety at baseline was significantly higher (RR = 1.80; 95% CI 1.242.61).”

    From Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis (2022) · cites this paper as [20]

  • The 13 eligible articles reported on 12 separate study populations containing 9192 patients.

    “The 13 eligible articles reported on 12 separate study populations,[11, 20-30, 33] containing 9192 patients.”

    From Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis (2022) · cites this paper as [20]

  • Five included studies scored 7 or more on the Newcastle-Ottawa scale.

    “Study quality is provided in Supplementary Tables 1 and 2; five studies scored 7 or more on the NewcastleOttawa scale.[11, 20, 23, 24, 26]”

    From Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis (2022) · cites this paper as [20]

  • Pooled from five studies including 1244 patients, the risk of developing a flare of disease activity was no higher among those with symptoms of anxiety at baseline (RR = 1.20; 95% CI 0.93-1.55), with moderate heterogeneity (I2 = 53.7%).

    “When data were pooled from five studies,[20, 26, 27, 29, 30] containing 1244 patients, the risk of developing a flare of disease activity was no higher among those with symptoms of anxiety at baseline (RR = 1.20; 95% CI 0.93-1.55), with moderate heterogeneity between studies ( I 2 =53.7%).”

    From Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis (2022) · cites this paper as [20]

  • Pooled from eight studies including 7606 patients, symptoms of depression at baseline were associated with a significantly increased risk of flare of disease activity during longitudinal follow-up (RR = 1.60; 95% CI 1.21-2.12), with high heterogeneity (I2 = 73.5%).

    “When data were pooled from eight studies,[20-23, 26, 27, 29, 30] which included 7606 patients, symptoms of depression at baseline were associated with a significantly increased risk of flare of disease activity during longitudinal follow-up (RR = 1.60; 95% CI 1.212.12), with high heterogeneity between studies ( I 2 =73.5%)”

    From Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis (2022) · cites this paper as [20]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Bitton, A., Dobkin, P. L., Edwardes, M. D., Sewitch, M. J., Meddings, J. B., Rawal, S., Cohen, A., Vermeire, S., Dufresne, L., Franchimont, D., & Wild, G. E.
Affiliations
  • McGill University Health Centre (CA)
  • University of Alberta (CA)
  • Jewish General Hospital (CA)
  • Universitair Ziekenhuis Leuven (BE)
  • Douglas Mental Health University Institute (CA)
Corresponding author
Bitton, A
ORCID
Venue
Gut
Publisher
BMJ
Published
2008-04-07
Volume
57
Issue
10
Pages
1386-1392
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
DOI
10.1136/gut.2007.134817
OpenAlex
W2028756447
Cited by
254
References
63
Citations by year
2026: 4 · 2025: 14 · 2024: 13 · 2023: 6 · 2022: 18 · 2021: 15 · 2020: 10 · 2019: 14 · 2018: 11 · 2017: 20 · 2016: 17 · 2015: 14 · 2014: 15 · 2013: 21 · 2012: 12
FWCI
9.52
Type
journal article
Language
en
Open access
closed
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
Keywords
Crohn's disease, recurrence prediction, biopsychosocial model, C-reactive protein, perceived stress, avoidance coping, colitis, serum cytokines, ASCA, intestinal permeability, psychosocial factors
MeSH terms
Adult, Blood Sedimentation, C-Reactive Protein, Crohn Disease, Female, Humans, Male, Models, Psychological, Permeability, Predictive Value of Tests, Prospective Studies, Recurrence, Stress, Psychological, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review